The molecular genetics of RASopathies: An update on novel disease genes and new disorders

Area of Science:

• Genetics and Molecular Biology
• Developmental Biology
• Signal Transduction

Background:

• RASopathies are a group of developmental disorders characterized by enhanced signaling through the RAS (Rat Sarcoma) and mitogen-associated protein kinase (MAPK) pathway.
• Increased RAS-MAPK signaling in RASopathies can stem from various molecular alterations, including upregulated RAS GTPases, enhanced positive regulators, or impaired negative feedback mechanisms.
• Over 20 genes have been linked to RASopathies in the past two decades, with ongoing research uncovering new disease mechanisms.

Purpose of the Study:

• To provide an overview of recent discoveries in RASopathies over the last five years.
• To highlight novel insights into the molecular basis of these disorders.
• To identify new RASopathies, associated genes, and regulatory circuits of RAS-MAPK signaling.

Main Methods:

• Review and synthesis of recent scientific literature on RASopathies.
• Analysis of gene discovery efforts and characterization of molecular mechanisms.
• Focus on findings from the past five years, including genetic and signaling pathway investigations.

Main Results:

• Recent research has yielded unexpected insights, such as the identification of Noonan syndrome as a recessive disorder.
• New RASopathies and disease-associated genes have been profiled.
• Novel molecular circuits involved in controlling RAS-MAPK signaling have been elucidated.

Conclusions:

• The last five years have significantly advanced our understanding of RASopathies, revealing new genetic and molecular complexities.
• Continued research is crucial for identifying novel therapeutic targets and improving diagnostic capabilities for RASopathies.
• The findings underscore the intricate regulation of the RAS-MAPK pathway in development and disease.